Arthritis Research & Therapy (Dec 2024)

Risk prediction of new-onset thrombocytopenia in patients with systemic lupus erythematosus: a multicenter prospective cohort study based on Chinese SLE treatment and research group (CSTAR) registry

  • Yupei Zhang,
  • Nan Jiang,
  • Xinwang Duan,
  • Jian Xu,
  • Lijun Wu,
  • Wei Wei,
  • Weiguo Xiao,
  • Li Luo,
  • Zhenyu Jiang,
  • Yanhong Wang,
  • Jiuliang Zhao,
  • Qian Wang,
  • Xinping Tian,
  • Mengtao Li,
  • Xiaofeng Zeng

DOI
https://doi.org/10.1186/s13075-024-03460-0
Journal volume & issue
Vol. 26, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Background Thrombocytopenia (TP) is a hematological manifestation of systemic lupus erythematosus (SLE) and is associated with unfavorable prognostic outcomes. This study aimed to develop a risk prediction model for new-onset TP in SLE patients. Methods Based on the multicenter prospective Chinese SLE Treatment and Research Group (CSTAR) registry, newly diagnosed SLE patients without TP at registration were enrolled. The least absolute shrinkage and selection operator (LASSO) method was used for variable selection. The final model was developed using multivariate Cox regression and displayed as a nomogram. Internal validation was achieved using enhanced Bootstrap resampling. Results During follow-up, thrombocytopenia developed in 80 (3.52%) of 2270 lupus patients. The final risk prediction model incorporated six predictors: baseline SDI score ≥ 1 (HR 2.207, 95% CI 1.350–3.609, p = 0.002), hemolytic anemia (HR 1.953, 95% CI 1.017–3.750, p = 0.044), low complement level (HR 2.351, 95% CI 1.004–5.505, p = 0.049), positive anti-β2GPI antibody (HR 1.805, 95% CI 1.084–3.004, p = 0.024), positive Coombs test (HR 1.878, 95% CI 1.123–3.141, p = 0.017), and positive anti-histone antibody (HR 1.595, 95% CI 1.017–2.587, p = 0.059). The model’s performance was indicated by C-index values for risk prediction at one, two, and three years, which were 0.741 (0.660–0.823), 0.730 (0.655–0.805), and 0.710 (0.643–0.777), respectively; and Brier scores of 0.018 (0.012–0.024), 0.025 (0.017–0.032), and 0.037 (0.027–0.046), respectively. Calibration curves were drawn and situated near the diagonal line. Conclusions This study developed the first risk prediction model for TP onset in lupus patients. Patients with baseline organ damage, hemolytic anemia, low complement, positive anti-histone antibody, positive anti-β2GPI antibody, or positive Coombs test were identified as being at high risk for thrombocytopenia and require further clinical attention.

Keywords